Clinics Ink $2M FCA Deal In Reimported Drugs Case

Law360, New York (January 24, 2014, 6:58 PM EST) -- A pair of Tennessee-based orthopedic clinics will shell out a combined $1.85 million to settle a whistleblower’s False Claims Act allegations that they illegally bought lower-cost prescription drugs from foreign sources in order to profit more off Medicare reimbursements, the U.S. Department of Justice said Friday.

Appalachian Orthopaedic Associates PC and Tennessee Orthopaedic Clinics PC, which did not admit any wrongdoing, were accused of breaching federal law by reimporting osteoarthritis medications. The process, which is generally unlawful, involves going outside the U.S. to purchase medicines that...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.